Company intelligence / Profile preview

BioSelective Capital Investments

Miami, Florida, United States

Ownership: Private
Development stage: Other

Overview

BioSelective Capital Investments is a specialized investment firm focused on the life sciences and biotechnology sectors. Based in Miami, Florida, the firm operates primarily as a hedge fund, managing a portfolio of public and private equity investments in healthcare companies. Led by Eduardo Abush, the firm utilizes a fundamental, research-driven approach to identify investment opportunities in innovative therapeutics, diagnostics, and medical technologies. BioSelective Capital is known for its active participation in the biotech capital markets, supporting companies through various stages of development. The firm's investment strategy emphasizes high-conviction positions in companies with the potential to address significant unmet medical needs.

Industry: Investors

Beyond the preview

Go deeper on BioSelective Capital Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioSelective Capital Investments.

Explore the full profile